Seeking Alpha
07 Oct 2026, 09:49 UTC · 1h ago
Lonza: The Market Is Pricing The Phasing, Not The Return On Capital
Impact · against what's priced in
Lonza shows strong operational momentum with margin expansion to 34.8% and a shift toward higher capital efficiency (13.2% ROIC). The combination of a CHF 500 million share buyback and strategic positioning to benefit from BIOSECURE policy shifts provides a positive catalyst for valuation expansion.
- LZN+0.50
No priced-in read yet
- In context
The company is transitioning to a pure-play CDMO with ROIC hitting 13.2% and CORE EBITDA margins rising to 34.8%, while using CHI divestiture proceeds for a CHF 500 million buyback.
Read from the article alone
Search tags
